Applied Med. Corp. v. Thomas

217 Cal. Rptr. 3d 169, 10 Cal. App. 5th 927, 2017 WL 1350761, 2017 Cal. App. LEXIS 337
CourtCalifornia Court of Appeal, 5th District
DecidedApril 12, 2017
DocketA145867
StatusPublished

This text of 217 Cal. Rptr. 3d 169 (Applied Med. Corp. v. Thomas) is published on Counsel Stack Legal Research, covering California Court of Appeal, 5th District primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Applied Med. Corp. v. Thomas, 217 Cal. Rptr. 3d 169, 10 Cal. App. 5th 927, 2017 WL 1350761, 2017 Cal. App. LEXIS 337 (Cal. Ct. App. 2017).

Opinions

SIMONS, J.

After defendant and respondent T. Peter Thomas ("Thomas"), a member of the Board of Directors of plaintiff and appellant Applied Medical Corporation ("Applied"), was removed from the Board, Applied exercised its right to repurchase shares of its stock issued to Thomas as part of certain stock incentive plans.

*172Thomas objected to the repurchase price, and in August 2012 Applied filed the instant lawsuit. In June, 2015, the trial court granted summary judgment against Applied, which timely appealed. We affirm as to Applied's fraud-based claims, but reverse as to Applied's claims based on breach of contract and conversion. In the published portion of this opinion we address two issues. First, the trial court erred in determining Applied's conversion claim failed. We conclude such a claim may be based on either ownership or the right to possession at the time of conversion. Second, we conclude the trial court correctly ruled Applied's fraud claims were barred by the applicable statute of limitations. We reject Applied's argument that those claims, first alleged in 2014, were timely under either the discovery rule or the relation back doctrine.

FACTUAL AND PROCEDURAL BACKGROUND 1

Applied is a provider of specialty medical products for surgical and minimally invasive procedures. Defendants and respondents Reid W. Dennis ("Dennis") and Thomas are general partners of Institutional Venture Management IV, L. P. ("IVM"). IVM is the general partner of defendant and respondent Institutional Venture Partners IV, L.P. ("IVP"), a venture-capital investment limited partnership. From 1988 to 1992, IVP made substantial financial investments in Applied. In 1988, Thomas joined Applied's Board of Directors ("Board").

In 1998 the Board approved Applied's 1998 Stock Incentive Plan (the "1998 Plan") regarding stock option awards. In 2003, the Board approved a stock option program proposed by Thomas for individuals serving as outside directors on the Board. Between 2003 and 2008, Thomas received five stock option grants pursuant to the 1998 Plan, and between 2009 and 2010, he received two stock option grants pursuant to Applied's Amended and Restated 2008 Stock Incentive Plan (the "2008 Plan").

The 1998 Plan included a provision giving Applied the unilateral right to repurchase shares upon termination of a director's service. The agreements corresponding to Thomas's grants under the 1998 Plan stated Applied would "have the right (but not the obligation) to repurchase ... any or all of the Shares acquired pursuant to the exercise" of the stock option upon termination of the optionee's service. Thomas acknowledged he, upon exercise of the repurchase right, "shall be obligated to sell his ... Shares to the Company." Thomas also represented the options were "being acquired ... for [his] personal account, for investment purposes only, and not with a view to the distribution, resale or other disposition thereof."

The 2008 Plan also gave Applied the right to repurchase shares from Thomas, and, in accepting stock option grants under the 2008 Plan, Thomas again acknowledged his obligation to sell his shares to Applied upon exercise of the company's repurchase right. Thomas also represented any shares would be acquired with his "own funds for investment for an indefinite period for your account, not as a nominee or agent, and not with a view to the sale or distribution of any part thereof," and that he had no "contract, understanding or *173agreement with any person to sell, transfer, or grant participation" to his options.

The IVM partners had an oral agreement regarding stock options obtained due to a partner's service on the board of directors of a company in which IVP had invested, like Applied. Under that agreement, the IVM partners provide the funds to purchase stock and, when the stock is sold, the proceeds are shared among the partners.2

According to Applied, Thomas did not disclose the stock-sharing agreement. Applied CEO Said Hilal ("Hilal") learned of the possibility that Thomas would share stock proceeds for the first time shortly before a Board meeting on or around February 24, 2011.3 Thomas said he "might share" the proceeds of the stock options awarded to him with his partners at IVP. Hilal was "surprised" by Thomas's suggestion because he considered it "completely contrary to the reason that the Company adopted a stock option program for directors in the first place-to compensate directors for their individual service." Thomas told Hilal he had "misunderstood;" Thomas said he was only "thinking about sharing his stock options" and he had not actually decided to do so. Thomas averred in his declaration that he "voluntarily disclosed the proceeds-sharing arrangement" to Hilal at the February 2011 Board meeting.

Applied raised concerns about the stock-sharing agreement in a December 1, 2011 e-mail from Applied's general counsel to Thomas. He wrote, "Said [Hilal] mentioned a discussion during the Applied Board meeting in February [2011], regarding the Applied stock options granted to you over the years. Our understanding is that you have an arrangement with IVP by which your Applied stock options are shared with your partners. You will recall that Said was surprised to learn of the arrangement, which was not known to Applied or the board. We believe the arrangement is inconsistent with the purpose of Applied's outside Director option program-to provide a form of compensation and incentive to the directors-for their service as directors. During that discussion with Said, you agreed to the cancellation of the options." Thomas replied that same day, stating *174"The stock options that I've earned over the years are not inconsistent with what your purpose [is.] It is to reward me. I own the shares and the shares are never going to be in any name but my name. Whether I share some of the proceeds of the sale in the future is my business and my sharing of the information with Said that I would probably share the benefits is for information only. I have no intention of ever putting any of those shares in the name of anybody but me. [¶] I also NEVER told Said that it was okay to cancel any of my shares and definitely am not willing to have those shares cancelled."

In January 2012, Thomas was voted off the Applied Board, apparently due to an alleged conflict of interest relating to IVP's efforts to compel Applied into an initial public offering in mid-2011.

On February 1, 2012, Thomas exercised his stock options and purchased 37,950 shares of Applied stock. On February 16, Applied confirmed the purchase and issued a stock certificate in Thomas's name. At the same time, Applied notified Thomas it was exercising its rights under the stock-option agreements to repurchase the shares. Applied stated the "Fair Market Value" of the shares was $13.05 each, and the company made available a check in the amount of $495,247.50. The 1998 and 2008 Plans set the repurchase price as the "Fair Market Value" of the shares, as determined "in good faith" by the Applied Board's Compensation Committee. Both plans state the determination "shall be conclusive and binding." The $13.05 purchase price for Thomas's shares was based on a valuation from a third-party firm that had performed valuations of Applied's stock since 2004.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pooshs v. Philip Morris USA, Inc.
250 P.3d 181 (California Supreme Court, 2011)
Norgart v. Upjohn Co.
981 P.2d 79 (California Supreme Court, 1999)
Hobart v. Hobart Estate Co.
159 P.2d 958 (California Supreme Court, 1945)
Wade v. Markwell & Co.
258 P.2d 497 (California Court of Appeal, 1953)
Samuels v. Mix
989 P.2d 701 (California Supreme Court, 1999)
Sun'n Sand, Inc. v. United California Bank
582 P.2d 920 (California Supreme Court, 1978)
Grudt v. City of Los Angeles
468 P.2d 825 (California Supreme Court, 1970)
Smeltzley v. Nicholson Manufacturing Co.
559 P.2d 624 (California Supreme Court, 1977)
April Enterprises, Inc. v. KTTV
147 Cal. App. 3d 805 (California Court of Appeal, 1983)
Rowland v. Superior Court
171 Cal. App. 3d 1214 (California Court of Appeal, 1985)
Cerra v. Blackstone
172 Cal. App. 3d 604 (California Court of Appeal, 1985)
Lamont v. Wolfe
142 Cal. App. 3d 375 (California Court of Appeal, 1983)
Weinstock v. Eissler
224 Cal. App. 2d 212 (California Court of Appeal, 1964)
Mears v. Crocker First National Bank
191 P.2d 501 (California Court of Appeal, 1948)
PCO, Inc. v. Christensen, Miller, Fink, Jacobs, Glaser, Weil & Shapiro
58 Cal. Rptr. 3d 516 (California Court of Appeal, 2007)
Plummer v. Day/Eisenberg, LLP
184 Cal. App. 4th 38 (California Court of Appeal, 2010)
Massey v. Mercy Medical Center Redding
180 Cal. App. 4th 690 (California Court of Appeal, 2009)
McCoy v. Gustafson
180 Cal. App. 4th 56 (California Court of Appeal, 2009)
King v. United Parcel Service, Inc.
60 Cal. Rptr. 3d 359 (California Court of Appeal, 2007)
Broberg v. Guardian Life Insurance Co. of America
171 Cal. App. 4th 912 (California Court of Appeal, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
217 Cal. Rptr. 3d 169, 10 Cal. App. 5th 927, 2017 WL 1350761, 2017 Cal. App. LEXIS 337, Counsel Stack Legal Research, https://law.counselstack.com/opinion/applied-med-corp-v-thomas-calctapp5d-2017.